Pharmaceuticals

Empliciti Market 2026 is seeing significant growth, fueled by the rising prevalence of multiple myeloma, which is driving increased demand and expanding market opportunities.

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Empliciti Market At The End Of The 2026–2030 Forecast Period?

Historical growth is linked to a rise in multiple myeloma cases, the restricted effectiveness of conventional chemotherapy, the initial achievements of monoclonal antibody medications, the increasing number of oncology treatment facilities, and greater financial backing for cancer research.

The anticipated market expansion throughout the forecast period is propelled by several factors, including the increasing utilization of immunotherapy protocols, a burgeoning pipeline of monoclonal antibody developments, enhanced survival rates necessitating long-term treatment solutions, advantageous reimbursement frameworks for oncology biologics, and breakthroughs in the creation of immune-based pharmaceuticals.

Significant trends expected during this period involve the emergence of combination monoclonal antibody therapies, cancer treatments specifically designed to target the immune system, a shift towards more individualized care for multiple myeloma, the escalating adoption of immunotherapy in cancer treatment, and the expanding implementation of long-term biologic regimens.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20055&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Empliciti Market?

The increasing incidence of multiple myeloma is anticipated to drive the expansion of the empliciti market moving forward. Multiple myeloma is a malignancy of the plasma cells, a category of white blood cells located in the bone marrow, resulting in atypical cell proliferation and potential harm to bones, kidneys, and the immune system. The prevalence of multiple myeloma is influenced by factors such as an aging population and advancements in diagnostic methods. Empliciti acts by targeting the SLAMF7 protein found on myeloma and natural killer (NK) cells, thereby enhancing the immune system’s capacity to identify and eliminate cancer cells. It improves NK cell activity and stimulates antibody-dependent cellular cytotoxicity (ADCC), which helps to slow disease progression when used in conjunction with other treatments. For instance, in August 2024, the American Cancer Society, a US-based non-profit organization, reported that approximately 35,780 new multiple myeloma cases were diagnosed in the United States in 2024, with 19,520 cases among men and 16,260 among women. Additionally, around 12,540 deaths are projected, including 7,020 in men and 5,520 in women. Consequently, the rising prevalence of multiple myeloma will propel the growth of the empliciti market.

What Segment Types Make Up The Empliciti Market?

The empliciti market covered in this report is segmented –

1) By Indication: Active Multiple Myeloma, Smoldering Multiple Myeloma

2) By Drug Class: Monoclonal Antibodies, Immunomodulatory Agents, Proteasome Inhibitors

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

Who Are The Key Players Driving Competition In The Empliciti Market?

Major companies operating in the empliciti market are Bristol-Myers Squibb Company

Read the full empliciti market report here:

https://www.thebusinessresearchcompany.com/report/empliciti-global-market-report

Which Regions Are Projected To Dominate The Empliciti Market In The Coming Years?

North America was the largest region in the empliciti market in 2025. The regions covered in the empliciti market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Empliciti Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20055&type=smp

Browse Through More Reports Similar to the Global Empliciti Market 2026, By The Business Research Company

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Vertical Market Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/vertical-market-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795